VanEck Pharmaceutical ETF
PPH
PPH
50 hedge funds and large institutions have $93M invested in VanEck Pharmaceutical ETF in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 5 closing their positions.
Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
14
Reduced
15
Closed
5
Calls
–
Puts
$339K
Net Calls
-$339K
Net Calls Change
-$206K
Top Buyers
1 |
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
|
$20.2M |
2 |
BCI
2
Brinker Capital Investments
Berwyn,
Pennsylvania
|
$8.54M |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$1.81M |
4 |
4
Jane Street
New York
|
$1.65M |
5 |
5
Morgan Stanley
New York
|
$5.44M |
Top Sellers
1 |
1
Bank of America
Charlotte,
North Carolina
|
$5.43M |
2 |
2
Goldman Sachs
New York
|
$14.8M |
3 |
3
SG Americas Securities
New York
|
$216K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$5.75M |
5 |
CC
5
Colrain Capital
Boston,
Massachusetts
|
$0 |